Cite
HARVARD Citation
Anton, J. et al. (2013). THU0490 Canakinumab Treatment of Patients with Hyper-IgD Syndrome: An Open-Label, Multicenter, Pilot Study. Annals of the rheumatic diseases. pp. A329-A330. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Anton, J. et al. (2013). THU0490 Canakinumab Treatment of Patients with Hyper-IgD Syndrome: An Open-Label, Multicenter, Pilot Study. Annals of the rheumatic diseases. pp. A329-A330. [Online].